Now is the time for Sinovac shareholders to stand up, speak out, and demand fairness from the Company's Board of Directors
Now is the time for Sinovac shareholders to stand up, speak out, and demand fairness from the Company's Board of Directors
Sinovac Fairness
For six years we Sinovac shareholders have been frustrated by management actions that left us unable to benefit from a historic bull run in vaccine stocks during the COVID-19 pandemic. Now the new board has an opportunity to correct this by distributing Sinovac's excessive cash of more than $10 billion with whom the cash belongs - we shareholders.
Join us to insist Sinovac's board do the right thing and return the cash to its rightful owners to compensate for this epic missed opportunity.
What Sinovac shareholders are saying
"...Expedite the Resumption of Trading..."
“As a long-trapped shareholder of Sinovac, I demand a fair resolution supported by transparency. I strongly urge Sinovac’s Board of Directors to expedite the resumption of trading of Sinovac’s shares on NASDAQ. The Company is represented by the prestigious law firm of Latham & Watkins LLP and its audits are conducted by Grant Thornton LLP. Further, OrbiMed Advisors LLC, a multi-billion dollar investment group based in the USA, is a significant investor in Sinovac. I call upon all the parties I have listed herein to do their part to ensure that ALL shareholders receive a fair deal. - C.F., Los Angeles, California, USA
"I Strongly Support the Call for Transparency, and Justice for Long-Standing Shareholders"
"I began investing in Sinovac in 2008 when I heard they were working on a vaccine for the H5N1 bird flu epidemic. I felt the vaccine market in China could be big and it would be a good hedge against any future pandemics. As a physician I was also impressed they authored articles that were published in major US medical journals. Needless to say I have been extremely disappointed in the unethical and unprofessional behavior of the company's leadership team, the endless lawsuits, the lack of transparency and the inability over the last 6 years in being able to access my money. How ironic that I was unable to have access to my shares when that pandemic did face the world! It is very disturbing to hear that $2.7 billion was distributed while our shares received nothing. I strongly support the call for transparency, and justice for long-standing shareholders who have been ignored for so many years." R.L & C.L., USA
What Sinovac shareholders are saying
"...Expedite the Resumption of Trading..."
“As a long-trapped shareholder of Sinovac, I demand a fair resolution supported by transparency. I strongly urge Sinovac’s Board of Directors to expedite the resumption of trading of Sinovac’s shares on NASDAQ.
The Company is represented by the prestigious law firm of Latham & Watkins LLP and its audits are conducted by Grant Thornton LLP.
Further, OrbiMed Advisors LLC, a multi-billion dollar investment group based in the USA, is a significant investor in Sinovac.
I call upon all the parties I have listed herein to do their part to ensure that ALL shareholders receive a fair deal.
~ C.F., Los Angeles, California, USA
"I Strongly Support the Call for Transparency, and Justice for Long-Standing Shareholders"
"I began investing in Sinovac in 2008 when I heard they were working on a vaccine for the H5N1 bird flu epidemic. I felt the vaccine market in China could be big and it would be a good hedge against any future pandemics. As a physician I was also impressed they authored articles that were published in major US medical journals.
Needless to say, I have been extremely disappointed in the … company's leadership team, the endless lawsuits, the lack of transparency and the inability over the last 6 years in being able to access my money. How ironic that I was unable to have access to my shares when that pandemic did face the world!
It is very disturbing to hear that $2.7 billion was distributed while our shares received nothing.
I strongly support the call for transparency, and justice for long-standing shareholders who have been ignored for so many years.."
~ R.L & C.L., USA
Download Our Letter to Sinovac shareholders for more information
Letter to Sinovac Shareholders March 2025
Document type: Letter | Date: March 20, 2025 | Language: English
Join our campaign. We will keep you updated about Sinovac and the need for fairness for shareholders.
We do not share your information with anyone whatsoever without your permission. Important: Please read our Terms of Use. Thank you!
Also, email your comments and inquiries to the Company:
CEO Mr. Weidong Yin: yinwd@sinovac.com
CFO Ms. Nan Wang: wangn@sinovac.com
Investor Relations, Ms. Helen Yang: yangg@sinovac.com
